Approval · Notice of Compliance 853 · 2002
ZELNORM: Notice of Compliance 853
Issued March 12, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 853
- Date
- March 12, 2002
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- 5-ht4 receptor partial agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZELNORM | 02245566 | — |
Medicinal ingredients
- TEGASEROD 6 MG per TAB